Jo R. De Mey
Odense, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Pericardial delta like non-canonical NOTCH ligand 1 (Dlk1) augments fibrosis in the heart through epithelial to mesenchymal transition.
Journal: Clinical and translational medicine
Published: August 01, 2023
The angiotensin AT2-receptor agonist compound 21 is an antagonist for the thromboxane TP-receptor - Implications for preclinical studies and future clinical use.
Journal: Peptides
Published: January 26, 2023
No guidelines for vascular nerves?
Journal: American journal of physiology. Heart and circulatory physiology
Published: March 24, 2022
Vasodilatation: One Question with Many Answers.
Journal: Journal of cardiovascular pharmacology
Published: November 29, 2021
Nitric oxide (NO) synthase but not NO, HNO or H2 O2 mediates endothelium-dependent relaxation of resistance arteries from patients with cardiovascular disease.
Journal: British journal of pharmacology
Published: February 11, 2021
Sympathetic and Sensory-Motor Nerves in Peripheral Small Arteries.
Journal: Physiological reviews
Published: December 03, 2020
Retinal Vascular Fractal Dimensions and Their Association with Macrovascular Cardiac Disease.
Journal: Ophthalmic research
Published: August 19, 2020
Local IGF Bioactivity Associates with High PAPP-A Activity in the Pericardial Cavity of Cardiovascular Disease Patients.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 03, 2020
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype.
Journal: PLoS biology
Published: February 01, 2020
Tribute to Paul M. Vanhoutte, MD, PhD (1940-2019).
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 27, 2019
Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease: Diagnostic and Additional Therapeutic Consequences.
Journal: Physiology (Bethesda, Md.)
Published: February 07, 2019
Neutral endopeptidase inhibitors blunt kidney fibrosis by reducing myofibroblast formation.
Journal: Clinical science (London, England : 1979)
Published: October 11, 2018
Last Updated: 09/26/2026